ZelosDx is a developing blood testing products to help researchers make breakthrough discoveries in brain health and disease.
ZelosDx has raised $256K in total funding. The most recent round was Grant. The last funding was announced in August 2021.
ZelosDx's investors include National Science Foundation, Michael J. Fox Foundation, Propel(X), MergeLane, Desert Angels.
ZelosDx is headquartered in Tucson, United States.
ZelosDx is a developing blood testing products to help researchers make breakthrough discoveries in brain health and disease.
ZelosDx is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ZelosDx — Funding & Investors." VCBacked, August 12, 2021, https://www.vcbacked.co/company/zelosdx. Accessed September 29, 2026.
VCBacked. (2021). ZelosDx — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/zelosdx
{{cite web |title=ZelosDx — Funding & Investors |url=https://www.vcbacked.co/company/zelosdx |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated